Cannabis Health Search

ACEA/ ARACHIDONYL-2'-CHLOROETHYLAMIDE - synthetic, CB1 agonist studies completed

Overview

Arachidonyl-2'-chloroethylamide (ACEA) is a synthetic agonist of the cannabinoid receptor 1 (CB1R). ACEA is considered to be a selective cannabinoid agonist as it binds primarily to the CB1R and has low affinity to the cannabinoid receptor 2 (CB2R) (Ki = 1.4 nM for CB1R; Ki = 3100 nM for CB2R).

Science & Research

Neurotoxicology.

Neuropsychopharmacology.

Neuroscience Letter.

Epilepsy Research.

2011 - Study ~ L-Type Calcium Channel Mediates Anticonvulsant Effect of Cannabinoids in Acute and Chronic Murine Models of Seizure.
Neurochemical Research.

Phytochemistry.

Neuropsychopharmacology.

Physiology & Behavior.

Neuropsychopharmacology and Biological Psychiatry.

Parmazie.

Epilepsy Research.

Journal of the International League Against Epilepsy.

British Journal of Pharmacology.

Neuropsychopharmacology.

American College of Rheumatology.

Journal of Neurophysiology.


Neuropsychopharmacology.

2007 - Study ~ Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis:
Journal of Pharmacology and Experimental Therapeutics.

Neuroscience Letter.

Institute of Pharmacology Polish Academy of Sciences.